Literature DB >> 8514796

Intermediates in degradation of the erythropoietin receptor accumulate and are degraded in lysosomes.

D Neumann1, L Wikström, S S Watowich, H F Lodish.   

Abstract

The erythropoietin receptor (EPO-R) is synthesized in transfected Ba/F3 cells as a major 64-kDa endoglycosidase H (Endo H)-sensitive species, with a single N-linked oligosaccharide, and a minor 62-kDa unglycosylated form. Approximately half of the newly made EPO-R is processed to a mature 66-kDa form with a Golgi-processed Endo H-resistant oligosaccharide, of which only a minor fraction is expressed at the cell surface. Both the Endo H-sensitive and the Endo H-resistant forms of the receptor have a half-life of 45-60 min (Yoshimura, A., D'Andrea, A. D., and Lodish, H. F. (1990) Proc. Natl. Acad. Sci. U. S. A. 87, 4139-4143). The mature, Endo H-resistant form of the EPO-R appears to be degraded in lysosomes or in other acidic organelles, since receptor degradation is blocked by treatment with NH4Cl, chloroquine, or leupeptin. A fraction of the Endo H-resistant EPO-R molecules is cleaved, generating two fragments of 46 and 39 kDa. The sizes of these fragments and their reactivities with carboxyl-terminal-specific antibodies indicate that the receptor is cleaved at two sites in the exoplasmic domain, 7 kDa apart, and carboxyl-terminal to the N-glycosylation site. Both fragments are membrane anchored and are probably formed in a late or post-Golgi compartment, since their formation is blocked by incubation of cells at 20 degrees C or by incubation with brefeldin A. These membrane-anchored COOH-terminal fragments are probably degraded in lysosomes or in other acidic vesicles as cell fractionation demonstrates that they colocalize with lysosomes, and similar to the intact EPO-R, their degradation is inhibited by NH4Cl. Finally, double labeling immunofluorescence experiments demonstrate that in NH4Cl-treated cells both intact mature EPO-R and the 46- and 39-kDa fragments accumulate in lysosomes and presumably are normally degraded there. The sensitivity of the EPO-R to endoproteolytic cleavages in its exoplasmic domain may relate to its low surface expression and to its extreme metabolic instability.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8514796

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  22 in total

1.  Ubiquitination regulates the internalization, endolysosomal sorting, and signaling of the erythropoietin receptor.

Authors:  Gamze Betul Bulut; Rita Sulahian; Yue Ma; Nai-wen Chi; Lily Jun-shen Huang
Journal:  J Biol Chem       Date:  2010-12-23       Impact factor: 5.157

2.  Erythropoietin induces tumor regression and antitumor immune responses in murine myeloma models.

Authors:  M Mittelman; D Neumann; A Peled; P Kanter; N Haran-Ghera
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

3.  Downregulation of erythropoietin receptor by overexpression of phospholipase C-gamma 1 is critical for decrease on focal adhesion in transformed cells.

Authors:  Jin Ku Kang; Chang-Hyun Chang; Hyo Jung Nam; Sung-Kuk Kim; Keun Jae Ahn; Heon Seok; Sang Joon Park; Yoon Joong Kang; Young Suk Jo; Minho Shong; Ho Kim
Journal:  Cell Oncol (Dordr)       Date:  2011-01-18       Impact factor: 6.730

4.  Phosphorylation of erythropoietin receptors in the endoplasmic reticulum by pervanadate-mediated inhibition of tyrosine phosphatases.

Authors:  J Cohen; H Altaratz; Y Zick; U Klingmüller; D Neumann
Journal:  Biochem J       Date:  1997-10-15       Impact factor: 3.857

5.  Erythropoietin receptor mRNA expression in human endothelial cells.

Authors:  A Anagnostou; Z Liu; M Steiner; K Chin; E S Lee; N Kessimian; C T Noguchi
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

6.  The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression.

Authors:  Josiane Ragimbeau; Elisabetta Dondi; Andrés Alcover; Pierre Eid; Gilles Uzé; Sandra Pellegrini
Journal:  EMBO J       Date:  2003-02-03       Impact factor: 11.598

7.  An extracellular region of the erythropoietin receptor of the subterranean blind mole rat Spalax enhances receptor maturation.

Authors:  Orly Ravid; Imad Shams; Nathalie Ben Califa; Eviatar Nevo; Aaron Avivi; Drorit Neumann
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-27       Impact factor: 11.205

8.  Blocking intracellular degradation of the erythropoietin and asialoglycoprotein receptors by calpain inhibitors does not result in the same increase in the levels of their membrane and secreted forms.

Authors:  D Neumann; M H Yuk; H F Lodish; G Z Lederkremer
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

9.  Increased cell surface expression and enhanced folding in the endoplasmic reticulum of a mutant erythropoietin receptor.

Authors:  D J Hilton; S S Watowich; P J Murray; H F Lodish
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-03       Impact factor: 11.205

10.  TYK2 activity promotes ligand-induced IFNAR1 proteolysis.

Authors:  Zrinka Marijanovic; Josiane Ragimbeau; K G Suresh Kumar; Serge Y Fuchs; Sandra Pellegrini
Journal:  Biochem J       Date:  2006-07-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.